The effect of vasopressin during hysteroscopic myomectomy in patients with submucosal myoma: A randomized controlled trial

Document Type : Original Article


Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran


Background: The aim was to assess the effect of vasopressin in reducing the time of surgery, amount of bleeding, and fluid deficit during hysteroscopic myomectomy of submucosal myoma from 2016 to 2018. Materials and methods: This study was conducted as a prospective, randomized, single-blinded clinical trial on the premenopausal women ranged from 18 to 62 years' old. A number of 80 patients were randomly assigned to each arm of the study according to random consecutive numbers. The control group (n = 40) of patients underwent conventional hysteroscopic myomectomy without vasopressin and the case group (n = 40) underwent hysteroscopic myomectomy with the injection of diluted vasopressin. Measured outcomes were time for myomectomy, fluid deficit, inflow volume, visual clarity, and postoperation hemoglobin level. Results: The mean time of myomectomy was 38.1 and 77.38 min in vasopressin and control groups, respectively (P < 0.001). The mean inflow volume was 2800 and 4100 in vasopressin and control groups, respectively (P = 0.029). The visual clarity score was 8.5 and 6.5 in the vasopressin and control groups, respectively (P < 0.001). Conclusions: The injection of vasopressin during hysteroscopic myomectomy is effective in the management of fluid deficit, time of surgery, and improvement of visual clarity.


Guo XC, Segars JH. The impact and management of fibroids for fertility: An evidence-based approach. Obstet Gynecol Clin 2012;39:521-33.  Back to cited text no. 1
Roy KK, Singla S, Baruah J, Sharma JB, Kumar S, Singh N. Reproductive outcome following hysteroscopic myomectomy in patients with infertility and recurrent abortions. Arch Gynecol Obstet 2010;282:553-60.  Back to cited text no. 2
Mettler L, Schollmeyer T, Tinelli A, Malvasi A, Alkatout I. Complications of uterine fibroids and their management, surgical management of fibroids, laparoscopy and hysteroscopy versus hysterectomy, haemorrhage, adhesions, and complications. Obstet Gynecol Int 2012;2012:791248.  Back to cited text no. 3
Wong L, Brun JL. Myomectomy: Technique and current indications. Minerva Ginecol 2014;66:35-47.  Back to cited text no. 4
American Association of Gynecologic Laparoscopists (AAGL): Advancing Minimally Invasive Gynecology Worldwide. AAGL practice report: Practice guidelines for the diagnosis and management of submucous leiomyomas. J Minim Invasive Gynecol 2012;19: 152.  Back to cited text no. 5
AAGL Advancing Minimally Invasive Gynecology Worldwide, Munro MG, Storz K, Abbott JA, Falcone T, Jacobs VR, et al. AAGL practice report: Practice guidelines for the management of hysteroscopic distending media: (replaces hysteroscopic fluid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000;7:167-168.  Back to cited text no. 6
Kongnyuy EJ, van Den Broek N, Wiysonge C. A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids. Int J Gynecol Obstet 2008;100:4-9.  Back to cited text no. 7
Ascher-Walsh CJ, Capes T, Smith J, Michels A. Cervical vasopressin compared with no premedication and blood loss during vaginal hysterectomy: A randomized controlled trial. Obstet Gynecol 2009;113:313-8.  Back to cited text no. 8
Song T, Kim MK, Kim ML, Jung YW, Yun BS, Seong SJ. Use of vasopressin vs epinephrine to reduce haemorrhage during myomectomy: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2015;195:177-81.  Back to cited text no. 9
Corson SL, Brooks PG, Serden SP, Batzer FR, Gocial B. Effects of vasopressin administration during hysteroscopic surgery. J Reprod Med 1994;39:419-23.  Back to cited text no. 10
Overdijk LE, Rademaker BM, van Kesteren PJ, de Haan P, Riezebos RK, Haude OC. The HYSTER study: The effect of intracervically administered terlipressin versus placebo on the number of gaseous emboli and fluid intravasation during hysteroscopic surgery: Study protocol for a randomized controlled clinical trial. Trials 2018;19:107.  Back to cited text no. 11
Canseco-Lima JM, Hernandez-Denis A, Audifred-Salomon J. Vasopressin myoma infiltration during hysteroscopic myomectomy. J Minim Invasive Gynecol 2015;22:S123.  Back to cited text no. 12
Ferguson J, Rattray D, Thiel J, Weins L. Intraoperative vasopressin injection during hysteroscopic myomectomy. Journal of Minimally Invasive Gynecology. 2016;23 (7):S146.  Back to cited text no. 13
Wong AS, Cheung CW, Yeung SW, Fan HL, Leung TY, Sahota DS. Transcervical intralesional vasopressin injection compared with placebo in hysteroscopic myomectomy: A randomized controlled trial. Obstet Gynecol 2014;124:897-903.  Back to cited text no. 14
Wamsteker K, Emanuel MH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: Results regarding the degree of intramural extension. Obstet Gynecol, 1993;82:736-40.  Back to cited text no. 15
Frederick J, Fletcher H, Simeon D, Mullings A, Hardie M. Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br J Obstet Gynaecol 1994;101:435-7.  Back to cited text no. 16
Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS, Khapra A, Ross PL. The effect of dilute vasopressin solution on blood loss during operative hysteroscopy: A randomized controlled trial. Obstet Gynecol 1996;88:761-6.  Back to cited text no. 17
Holloran-Schwartz MB, Harrison K, Gimpelson R. Direct injection of vasopressin during hysteroscopic myomectomy: A case report. J Reprod Med 2014;59:614-6.  Back to cited text no. 18
Samy A, Raslan AN, Talaat B, El Lithy A, El Sharkawy M, Sharaf MF, et al. Perioperative nonhormonal pharmacological interventions for bleeding reduction during open and minimally invasive myomectomy: A systematic review and network meta-analysis. Fertil Steril 2020;113:224-33.e6.  Back to cited text no. 19